AnaptysBio earnings missed by $0.34, revenue fell short of estimates
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Bitcoin vs Ethereum: Which crypto asset could deliver better returns in the next 12 months?
AI is the clearest example. It raises the prospect of a permanent growth breakout, accelerating innovation itself and compressing decade long timelines into a few years
US consumer prices accelerate in August, push Fed closer to rate hike
In August, consumer prices surged, strengthening the anticipation of Federal Reserve rate hikes. The core inflation saw its most substantial rise in four months, pointing to ongoing price pressures…
BRICS can help Global South build resilience beyond supply chains: China Daily ahead of Xi-Modi meeting
BRICS Summit: Chinese President XI Jinping is landing in New Delhi to take part in BRICS Summit 2026 in New Delhi today. This will be Xi's first visit to India in nearly seven years.
Rs 24,600 crore IPO dhamaka: NSE, Hero Motors to lead 11 public offers next week
NSE will be the biggest issue of the week, with an IPO size of Rs 22,562 crore. Hero Motors will follow with a Rs 1,000 crore issue.
NSE IPO: Market dominance vs regulatory risks; what investors should know from the RHP
In its red herring prospectus (RHP), NSE has highlighted its market leadership, scale, profitability, technology infrastructure and cash generation as key strengths.